'Real world' pragmatic clinical trials: what are they and what do they tell us?

Peter Joseph Benedict Helms

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Although the explanatory clinical therapeutic trial remains the foundation for assessing drug efficacy and is required for licensing purposes, the overall effectiveness of a treatment can be best judged by carefully designed and well conducted pragmatic 'real world' randomized trials. Pragmatic trials seek to inform prescribers and health care planners on the most effective and cost beneficial treatments. Pragmatic trials deserve more attention and should be included in evidence based guidelines for the pharmacological management of common diseases such as asthma and atopy.

Original languageEnglish
Pages (from-to)4-9
Number of pages5
JournalPediatric Allergy & Immunology
Volume13
Issue number1
DOIs
Publication statusPublished - 2002

Keywords

  • LABEL DRUG-USE
  • CHILDHOOD ASTHMA
  • BECLOMETHASONE DIPROPIONATE
  • INHALED CORTICOSTEROIDS
  • FLUTICASONE PROPIONATE
  • CHILDREN
  • BUDESONIDE
  • MEDICATION
  • EFFICACY
  • SAFETY

Cite this

'Real world' pragmatic clinical trials: what are they and what do they tell us? / Helms, Peter Joseph Benedict.

In: Pediatric Allergy & Immunology, Vol. 13, No. 1, 2002, p. 4-9.

Research output: Contribution to journalArticle

@article{b42219c3ba4a4e7591a596603aeaebd2,
title = "'Real world' pragmatic clinical trials: what are they and what do they tell us?",
abstract = "Although the explanatory clinical therapeutic trial remains the foundation for assessing drug efficacy and is required for licensing purposes, the overall effectiveness of a treatment can be best judged by carefully designed and well conducted pragmatic 'real world' randomized trials. Pragmatic trials seek to inform prescribers and health care planners on the most effective and cost beneficial treatments. Pragmatic trials deserve more attention and should be included in evidence based guidelines for the pharmacological management of common diseases such as asthma and atopy.",
keywords = "LABEL DRUG-USE, CHILDHOOD ASTHMA, BECLOMETHASONE DIPROPIONATE, INHALED CORTICOSTEROIDS, FLUTICASONE PROPIONATE, CHILDREN, BUDESONIDE, MEDICATION, EFFICACY, SAFETY",
author = "Helms, {Peter Joseph Benedict}",
year = "2002",
doi = "10.1034/j.1399-3038.2002.00194.x",
language = "English",
volume = "13",
pages = "4--9",
journal = "Pediatric Allergy & Immunology",
issn = "0905-6157",
publisher = "Blackwell Munksgaard",
number = "1",

}

TY - JOUR

T1 - 'Real world' pragmatic clinical trials: what are they and what do they tell us?

AU - Helms, Peter Joseph Benedict

PY - 2002

Y1 - 2002

N2 - Although the explanatory clinical therapeutic trial remains the foundation for assessing drug efficacy and is required for licensing purposes, the overall effectiveness of a treatment can be best judged by carefully designed and well conducted pragmatic 'real world' randomized trials. Pragmatic trials seek to inform prescribers and health care planners on the most effective and cost beneficial treatments. Pragmatic trials deserve more attention and should be included in evidence based guidelines for the pharmacological management of common diseases such as asthma and atopy.

AB - Although the explanatory clinical therapeutic trial remains the foundation for assessing drug efficacy and is required for licensing purposes, the overall effectiveness of a treatment can be best judged by carefully designed and well conducted pragmatic 'real world' randomized trials. Pragmatic trials seek to inform prescribers and health care planners on the most effective and cost beneficial treatments. Pragmatic trials deserve more attention and should be included in evidence based guidelines for the pharmacological management of common diseases such as asthma and atopy.

KW - LABEL DRUG-USE

KW - CHILDHOOD ASTHMA

KW - BECLOMETHASONE DIPROPIONATE

KW - INHALED CORTICOSTEROIDS

KW - FLUTICASONE PROPIONATE

KW - CHILDREN

KW - BUDESONIDE

KW - MEDICATION

KW - EFFICACY

KW - SAFETY

U2 - 10.1034/j.1399-3038.2002.00194.x

DO - 10.1034/j.1399-3038.2002.00194.x

M3 - Article

VL - 13

SP - 4

EP - 9

JO - Pediatric Allergy & Immunology

JF - Pediatric Allergy & Immunology

SN - 0905-6157

IS - 1

ER -